Keywords: BPC 157, Budd Chiari syndrome, Portal/caval hypertension Core tip: To demonstrate that pentadecapeptide BPC 157 can resolve Budd Chiari syndrome in rats, we provided gross, microscopy, nitric oxide-, malondialdehyde-liver levels, serum enzymes, electrocardiogram, portal, caval hypertension, aortal hypotension, thrombosis, hepatomegaly, splenomegaly and venography assessments
doi: 10.3390/ijms22095010
Lasting Stability: Maintains structure and potency under proper storage
doi: 10.1016/j.biopha.2016.04.022 31 MorimitsuYNakagawaYHayashiKFujiiHKumagaiTNakamuraYet al
About Mile High Compounds Colorado-based research compound supplier specializing in high-purity reference materials for laboratory applications